New study tests best way to tackle lung clots: surgery, Low-Dose drugs, or standard care?
NCT ID NCT06453876
First seen Apr 16, 2026 · Last updated May 09, 2026 · Updated 2 times
Summary
This study looks at 210 people with a serious type of blood clot in the lungs (intermediate high-risk pulmonary embolism). It compares three approaches: a procedure to remove the clot, a low-dose clot-busting drug, or standard blood thinners. The goal is to see which method reduces clot size best and improves recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen University Hospital Rigshospitalet
Copenhagen, DK2100, Denmark
-
Odense University Hospital
Odense, 5000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.